Finance News – Prescription Drugs
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Ceo
Investors
Tariffs
Shares
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Xrp
Etf
Bse
Stablecoin
Blockchain
Investment
Ipo
Eth
Sec
Index
Solana
Trade
Inflation
Earnings
Interest Rates
Sensex
Coinbase
Token
Revenue
Wall Street
Nasdaq
Treasury
China
Nse
Federal Reserve
Traders
Bse Sensex
Nifty
Sp 500
Gold
Tesla
Investor
Economy
Profit
Defi
Public Offering
Ohio
White Paper
Gamefi
Business Risk
Federal Housing
Payment Toolkit
Chip Business
Debt Conversions
Energy Rules
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
MarketWatch Top Stories • May 13, 2025
Trump is right about drug prices. He’s just going about it all wrong.
The current approach to addressing medication costs has not convinced investors, reflecting uncertainty about its impact on the pharmaceutical industry and overall market stability...
Read Full Article →
CNBC Business • May 12, 2025
Trump signs order aiming to cut some U.S. drug prices to match lower ones abroad
The executive action seeks to reduce prescription medication costs by aligning U.S. prices with those in other countries, potentially impacting pharmaceutical companies amid upcomi...
Read Full Article →